Hyaluronic acid containing pharmaceutical or veterinary compositions
OwnerAnthony Michael Chandlerinventor
Life of this patent
Estimating the term…
Abstract
A pharmaceutical or veterinary composition comprises a hyaluronic acid or a salt thereof or an ester of hyaluronic acid with an alcohol of the aliphatic, heterocyclic or cycloaliphatic series, or a sulphated form of hyaluronic acid, together with at least one eicosanoid or tetraenoic polyunsaturated fatty acid or an ester or a salt thereof, preferably in the form of an extract of fatty acids from the New Zealand Green Lipped Mussel Perna canaliculus. The compositions are active against inflammatory conditions including osteoarthritis.
Claims20
A pharmaceutical or veterinary composition comprising
- a) a hyaluronic acid or a salt thereof or an ester of hyaluronic acid with an alcohol of the aliphatic, heterocyclic or cycloaliphatic series, or a sulphated form of hyaluronic acid, together with
- b) an extract of fatty acids from Perna canaliculus providing at least one eicosanoid or tetraenoic polyunsaturated fatty acid or an ester or a salt thereof, components (a) and (b) being present in amounts producing a synergistic effect when used in the treatment or prophylaxis of an arthritic or other inflammatory condition.
A pharmaceutical or veterinary composition comprising
- a) a hyaluronic acid or a salt thereof or an ester of hyaluronic acid with an alcohol of the aliphatic, heterocyclic or cycloaliphatic series, or a sulphated form of hyaluronic acid, together with
- b) an extract of fatty acids from Perna canaliculus,
- said composition providing a more rapid benefit than administration of (a) alone.
A method of therapy comprising administering to a mammal suffering from an arthritic condition or other inflammatory condition, or in need of prophylaxis in respect of such a condition, synergistic amounts of a hyaluronic acid or a salt thereof or an ester of hyaluronic acid with an alcohol of the aliphatic, heterocyclic or cycloaliphatic series, or a sulphated form of hyaluronic acid, together with at least one eicosanoid or tetraenoic polyunsaturated fatty acid or ester thereof or a slat of a said fatty acid, separately or as an admixture.
Dependencies are inferred from the claim text.